Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib

Clinical trial NCT04770688 · COMPLETED

Trial details

NCT number: NCT04770688
Sponsor: Shanghai Chest Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer With EGFR Mutation Locally Advanced Solid Tumor Metastatic Cancer Adenocarcinoma of Lung

Start date: 2020-11-19
Primary completion: 2024-06-20
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.